In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Discover the five major risk factors for kidney disease, from daily habits to genetic predisposition, and learn the warning ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...

"Learn about the importance of kidney health and comprehensive screening during National Kidney Month. Discover how CarelonRx ...

Uganda has made significant strides in kidney care, including the establishment of dialysis centres and successful kidney ...